William Jia
About William Jia
Chief Scientific Officer and Co-Founder
William Jia holds the title of Chief Scientific Officer and Co-Founder. In his role, he is responsible for providing scientific leadership and direction for the company's research and development initiatives. His expertise in oncolytic virotherapy plays a significant part in the company's mission and goals. As a co-founder, he is integral to the strategic planning and growth of the organization, working closely with the executive team to drive innovation and scientific advancement.
Education and Expertise
William Jia holds a PhD, which underscores his extensive knowledge and research capabilities in his field. His advanced education provides a solid foundation for his work in oncolytic virotherapy, a specialized area of cancer treatment that involves using viruses to target and destroy cancer cells. His expertise is frequently sought after for various scientific discussions and conferences.
Presentation at 14th International Oncolytic Virotherapy Conference
On October 24, 2022, William Jia presented 'New strategies for oncolytic virotherapy: turning anti-viral immunity to anti-tumor' at the 14th International Oncolytic Virotherapy Conference in Nagano, Japan. His presentation focused on innovative approaches to harnessing the body's immune response, redirecting it from fighting viruses to targeting tumors. This event is a significant platform for sharing advancements in cancer treatment, and William's contribution underscores his prominence in the field.